Mago-Nashi Homolog (MAGOH) (Middle Region) Peptide
Quick Overview for Mago-Nashi Homolog (MAGOH) (Middle Region) Peptide (ABIN8104756)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- MAGOH Peptide - middle region
-
Sequence
- FGHEFLEFEF RPDGKLRYAN NSNYKNDVMI RKEAYVHKSV MEELKRIIDD
-
-
Mago-Nashi Homolog (MAGOH) peptide
MAGOH Reactivity: Human, Cow, Dog, Mouse, Rat Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- MAGOH Antibody (ARP87634_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MAGOH (Mago-Nashi Homolog (MAGOH))
-
Background
-
Background Information: Drosophila that have mutations in their mago nashi (grandchildless) gene produce progeny with defects in germplasm assembly and germline development. This gene encodes the mammalian mago nashi homolog. In mammals, mRNA expression is not limited to the germ plasm, but is expressed ubiquitously in adult tissues and can be induced by serum stimulation of quiescent fibroblasts.
Alternative Symbols: MAGOH1, MAGOHA
-
Molecular Weight
- 16 kDa
-
Gene ID
- 4116
-
NCBI Accession
- NP_002361
-
UniProt
- P61326
Target
-
